Loading clinical trials...
Loading clinical trials...
A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]-Pevonedistat in Patients With Advanced Solid Tumors
Conditions
Interventions
Pevonedistat
[14C]-Pevonedistat
+3 more
Locations
2
Hungary
Magyar Honvédség Egészségügyi Központ Onkológiai osztály
Budapest, Hungary
PRA Magyarország Kft. Fázis I-es Klinikai Farmakológiai Vizsgálóhely
Budapest, Hungary
Start Date
May 11, 2017
Primary Completion Date
February 8, 2018
Completion Date
November 5, 2018
Last Updated
November 18, 2019
Lead Sponsor
Millennium Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions